Dr. Karim Al-Azizi and Dr. C. Michael Gibson discuss: Caveat Emptor: Advantages and Disadvantages of Current Generation Tools for Evaluation of Coronary Atherosclerosis
Sponsored by Cleerly, Women as One and International Atherosclerosis Society
.
Search
Dr. Nicole Cyrille Superville and Dr. C. Michael Gibson discuss: Demographic Disparities in Tafamidis Treatment and Clinical Outcomes Across the United States
Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.
Dr. Fatima Rodriguez and Dr. C. Michael Gibson discuss: A Proposed Stepwise Approach to Evaluation, Treatment and Tracking of Coronary Atherosclerosis
Sponsored by Cleerly, Women as One and International Atherosclerosis Society
Dr. Sandesh Dev and Dr. C. Michael Gibson discuss: Geographic Disparities in Transthyretin Amyloid Cardiomyopathy Prevalence in United States Veterans.
Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.
Dr. Jim Januzzi and Dr. C. Michael Gibson discuss: Acoramidis Lowers NT-proBNP in a Larger Proportion of ATTRibute-CM Study Participants With Transthyretin Amyloid.
Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.